Physician

Nicholas Berlon, M.D.

According to 2025 Medicare claims, Nicholas Berlon, M.D. (NPI: 1619361169) practices internal medicine in the Muncie, IN market, with the plurality of this provider's patient population coming from Delaware, IN. This provider's primary affiliated billing organization is ROYALE INTERNAL MEDICINE, LLC (NPI: 1225450836; TIN: 46-3986500) and primary practice location at 47304-2264. Berlon is affiliated with the Aledade 103 Upper Midwest MSSP (ACO ID: A5003), participating under the MSSP model.

Berlon's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 242 traditional Medicare patients, billed 5,100 HCPCS/CPT codes, and received $119,406 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 4,344 prescription claims across 505 beneficiaries totaling $514,756 in drug costs, led by Eliquis (Apixaban). DME data shows 70 claims. Open Payments data shows 116 records totaling $2,172. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $16,768 to $119,406. Similarly, Part D prescription costs have risen steadily, from $612 to $514,756. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	123	288	$16,768
2019	605	2,761	$64,753
2020	487	4,695	$65,140
2021	556	1,195	$74,441
2022	558	1,148	$72,076
2023	475	1,896	$70,095
2024	242	5,100	$119,406

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	17	$612
2016	15	39	$6,641
2017	11	34	$470
2018	28	63	$15,358
2019	253	1,282	$168,013
2020	314	4,305	$542,390
2021	381	4,827	$667,721
2022	425	5,112	$801,135
2023	491	3,916	$563,572
2024	505	4,344	$514,756

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	12	$571
2020	N/R	157	$10,386
2021	N/R	178	$12,734
2022	N/R	111	$9,002
2023	N/R	151	$14,989
2024	N/R	70	$6,805

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	205	489	$78
80053	Blood test, comprehensive group of blood chemicals	173	255	$10
84439	Thyroxine (thyroid chemical), free	168	193	$9
36415	Insertion of needle into vein for collection of blood sample	191	361	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	171	246	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	65	4,804	$90,591
Mounjaro	Tirzepatide	59	2,044	$73,967
Ozempic	Semaglutide	40	1,960	$62,654
Farxiga	Dapagliflozin Propanediol	57	3,146	$58,317
Jardiance	Empagliflozin	35	2,723	$51,669

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	16	$4,325
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	15	$1,236
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	N/R	14	$987
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	N/R	14	$155
A7038	Filter, disposable, used with positive airway pressure device	N	N/R	11	$102

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	116	$2,172	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Nicholas Berlon, M.D.?

Tedicare shows public-source Medicare data for Nicholas Berlon, M.D. (NPI 1619361169), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nicholas Berlon, M.D. have ACO affiliation data?

Nicholas Berlon, M.D. is shown with ACO affiliation data for Aledade 103 Upper Midwest MSSP (MSSP, ACO ID A5003).

What billing organization is linked to Nicholas Berlon, M.D.?

Nicholas Berlon, M.D. is linked to ROYALE INTERNAL MEDICINE, LLC (billing NPI 1225450836) in the available physician profile data.

Does Nicholas Berlon, M.D. have Open Payments data?

Nicholas Berlon, M.D. has 116 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.